JAMIE FLETCHER: Open Payments
NPI 1699002675 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,404 in 83 payments from 19 companies in 2025. Trend: 2023 $3,186 · 2024 $1,659 · 2025 $2,404
Food & beverage: $2,404
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $534 |
| Lilly USA, LLC | 8 | $368 |
| Axsome Therapeutics, Inc. | 10 | $310 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $216 |
| AstraZeneca Pharmaceuticals LP | 4 | $189 |
| ABBVIE INC. | 13 | $151 |
| Amgen Inc. | 2 | $123 |
| Kowa Pharmaceuticals America, Inc. | 1 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $82 |
| PFIZER INC. | 3 | $60 |
Products named: Auvelity, Wegovy, MOUNJARO, CAPLYTA, AIRSUPRA, Ozempic, KISUNLA, TAVNEOS.
Industry payments across TX — which companies pay providers there.
